Lead Product(s) : Dimiracetam
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Dimiracetam in Painful Neuropathies Affecting AIDS Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 03, 2011
Lead Product(s) : Dimiracetam
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dimiracetam
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Cross Research S.A. | Triclinium clinical trial project managment LTD
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 02, 2010
Lead Product(s) : Dimiracetam
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Cross Research S.A. | Triclinium clinical trial project managment LTD
Deal Size : Inapplicable
Deal Type : Inapplicable